Management of patients with hepatitis C virus resistance-associated variants to NS5A inhibitors: Where are we now?
- PMID: 31040995
- PMCID: PMC6490661
- DOI: 10.1002/cld.507
Management of patients with hepatitis C virus resistance-associated variants to NS5A inhibitors: Where are we now?
Figures
References
-
- McGovern BH, Abu Dayyeh BK, Chung RT. Avoiding therapeutic pitfalls: the rational use of specifically targeted agents against hepatitis C infection. Hepatology 2008;48:1700‐1712. - PubMed
-
- Blight KJ, Kolyhalov AA, Reed KE, Agapov EV, Rice CM. Molecular virology of hepatitis C virus: an update with respect to potential antiviral targets. Antiviral Ther 1998;3:71‐81. - PubMed
-
- Lindenbach B, Rice CM. Unraveling hepatitis C virus replication from genome to function. Nature 2005;436:933‐938. - PubMed
-
- Kieffer TL. Viral resistance to specifically targeted antiviral therapies for hepatitis C (STAT‐Cs). J Antimicrob Chemother 2010;65:202‐212. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources